Association of Protein Z with Prediabetes and Type 2 Diabetes
Background Type 2 diabetes mellitus (T2DM) is a progressive metabolic disease. Early detection of prediabetes is important to reduce the risk of T2DM. Some cytokines are known to be associated with T2DM. Therefore, we aimed to identify cytokines as novel biomarkers of glucose dysmetabolism. Methods...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academya Publishing Co.
2021-06-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.e-enm.org/upload/pdf/enm-2021-962.pdf |
id |
doaj-68cf8e811e344d1ca71d78f9b7f20a22 |
---|---|
record_format |
Article |
spelling |
doaj-68cf8e811e344d1ca71d78f9b7f20a222021-07-05T06:12:46ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782021-06-0136363764610.3803/EnM.2021.9622171Association of Protein Z with Prediabetes and Type 2 DiabetesYun-Ui Bae0Ji Hong You1Nan Hee Cho2Leah Eunjung Kim3Hye Min Shim4Jae-Hyung Park5Ho Chan Cho6 Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea Department of Physiology, Keimyung University School of Medicine, Daegu, Korea Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, KoreaBackground Type 2 diabetes mellitus (T2DM) is a progressive metabolic disease. Early detection of prediabetes is important to reduce the risk of T2DM. Some cytokines are known to be associated with T2DM. Therefore, we aimed to identify cytokines as novel biomarkers of glucose dysmetabolism. Methods The first stage of the study included 43 subjects (13 subjects with newly diagnosed T2DM, 13 with prediabetes, and 16 with normoglycemia) for cytokine microarray analysis. Blood samples of the subjects were assessed for 310 cytokines to identify potential indicators of prediabetes. The second stage included 142 subjects (36 subjects with T2DM, 35 with prediabetes, and 71 with normoglycemia) to validate the potential cytokines associated with prediabetes. Results We identified 41 cytokines that differed by 1.5-fold or more in at least one out of the three comparisons (normoglycemia vs. prediabetes, normoglycemia vs. T2DM, and prediabetes vs. T2DM) among 310 cytokines. Finally, we selected protein Z (PROZ) and validated this finding to determine its association with prediabetes. Plasma PROZ levels were found to be decreased in patients with prediabetes (1,490.32±367.19 pg/mL) and T2DM (1,583.34±465.43 pg/mL) compared to those in subjects with normoglycemia (1,864.07±450.83 pg/mL) (P<0.001). There were significantly negative correlations between PROZ and fasting plasma glucose (P=0.001) and hemoglobin A1c (P=0.010). Conclusion PROZ levels were associated with prediabetes and T2DM. We suggest that PROZ may be a promising biomarker for the early detection of prediabetes. Further large-scale studies are needed to evaluate the relationship and mechanism between PROZ and prediabetes and T2DM.http://www.e-enm.org/upload/pdf/enm-2021-962.pdfprotein zprediabetic statediabetes mellitustype 2biomarkerscytokines |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yun-Ui Bae Ji Hong You Nan Hee Cho Leah Eunjung Kim Hye Min Shim Jae-Hyung Park Ho Chan Cho |
spellingShingle |
Yun-Ui Bae Ji Hong You Nan Hee Cho Leah Eunjung Kim Hye Min Shim Jae-Hyung Park Ho Chan Cho Association of Protein Z with Prediabetes and Type 2 Diabetes Endocrinology and Metabolism protein z prediabetic state diabetes mellitus type 2 biomarkers cytokines |
author_facet |
Yun-Ui Bae Ji Hong You Nan Hee Cho Leah Eunjung Kim Hye Min Shim Jae-Hyung Park Ho Chan Cho |
author_sort |
Yun-Ui Bae |
title |
Association of Protein Z with Prediabetes and Type 2 Diabetes |
title_short |
Association of Protein Z with Prediabetes and Type 2 Diabetes |
title_full |
Association of Protein Z with Prediabetes and Type 2 Diabetes |
title_fullStr |
Association of Protein Z with Prediabetes and Type 2 Diabetes |
title_full_unstemmed |
Association of Protein Z with Prediabetes and Type 2 Diabetes |
title_sort |
association of protein z with prediabetes and type 2 diabetes |
publisher |
Academya Publishing Co. |
series |
Endocrinology and Metabolism |
issn |
2093-596X 2093-5978 |
publishDate |
2021-06-01 |
description |
Background Type 2 diabetes mellitus (T2DM) is a progressive metabolic disease. Early detection of prediabetes is important to reduce the risk of T2DM. Some cytokines are known to be associated with T2DM. Therefore, we aimed to identify cytokines as novel biomarkers of glucose dysmetabolism. Methods The first stage of the study included 43 subjects (13 subjects with newly diagnosed T2DM, 13 with prediabetes, and 16 with normoglycemia) for cytokine microarray analysis. Blood samples of the subjects were assessed for 310 cytokines to identify potential indicators of prediabetes. The second stage included 142 subjects (36 subjects with T2DM, 35 with prediabetes, and 71 with normoglycemia) to validate the potential cytokines associated with prediabetes. Results We identified 41 cytokines that differed by 1.5-fold or more in at least one out of the three comparisons (normoglycemia vs. prediabetes, normoglycemia vs. T2DM, and prediabetes vs. T2DM) among 310 cytokines. Finally, we selected protein Z (PROZ) and validated this finding to determine its association with prediabetes. Plasma PROZ levels were found to be decreased in patients with prediabetes (1,490.32±367.19 pg/mL) and T2DM (1,583.34±465.43 pg/mL) compared to those in subjects with normoglycemia (1,864.07±450.83 pg/mL) (P<0.001). There were significantly negative correlations between PROZ and fasting plasma glucose (P=0.001) and hemoglobin A1c (P=0.010). Conclusion PROZ levels were associated with prediabetes and T2DM. We suggest that PROZ may be a promising biomarker for the early detection of prediabetes. Further large-scale studies are needed to evaluate the relationship and mechanism between PROZ and prediabetes and T2DM. |
topic |
protein z prediabetic state diabetes mellitus type 2 biomarkers cytokines |
url |
http://www.e-enm.org/upload/pdf/enm-2021-962.pdf |
work_keys_str_mv |
AT yunuibae associationofproteinzwithprediabetesandtype2diabetes AT jihongyou associationofproteinzwithprediabetesandtype2diabetes AT nanheecho associationofproteinzwithprediabetesandtype2diabetes AT leaheunjungkim associationofproteinzwithprediabetesandtype2diabetes AT hyeminshim associationofproteinzwithprediabetesandtype2diabetes AT jaehyungpark associationofproteinzwithprediabetesandtype2diabetes AT hochancho associationofproteinzwithprediabetesandtype2diabetes |
_version_ |
1721318858226139136 |